(Q36322140)

13 August 2017

1 reference

title

Drug-resistant tuberculosis: controversies and challenges in pediatrics (English)

1 reference

13 August 2017

1 reference

Kim Connelly Smith

1

1 reference

PubMed ID

16307511

13 August 2017

Barbara J Seaworth

series ordinal

2

1 reference

PubMed ID

16307511

13 August 2017

language of work or name

1 reference

1 December 2005

1 reference

Expert Review of Anti-infective Therapy

13 August 2017

1 reference

13 August 2017

3

1 reference

13 August 2017

6

1 reference

13 August 2017

995-1010

1 reference

The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis

13 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

Treatment of multidrug-resistant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

Culture confirmed multidrug resistant tuberculosis: diagnostic delay, clinical features, and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

How many sputum specimens are necessary to diagnose pulmonary tuberculosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

Molecular detection of antimicrobial resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

Should bronchoscopy be performed in the evaluation of suspected pediatric pulmonary tuberculosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

Comparison of bronchoscopy and gastric washings in the investigation of smear-negative pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

Current concepts of childhood tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

Missed opportunities for preventing tuberculosis among children younger than five years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

Evaluation of young children in contact with adult multidrug-resistant pulmonary tuberculosis: a 30-month follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

Transmission of multidrug-resistant tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

Ethambutol in tuberculosis: time to reconsider?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

Potential role of fluoroquinolone therapy in childhood otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

Pediatric urinary tract infections: the role of fluoroquinolones

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

Treatment and Outcome Analysis of 205 Patients with Multidrug-resistant Tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

Pharmacokinetic and pharmacodynamic issues in the treatment of mycobacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

Novel treatment of meningitis caused by multidrug-resistant Mycobacterium tuberculosis with intrathecal levofloxacin and amikacin: case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

Effect of corticosteroids on intracranial pressure, computed tomographic findings, and clinical outcome in young children with tuberculous meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

Advances in adjuvant therapy against acute bacterial meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

Multidrug-resistant tuberculous meningitis in KwaZulu-Natal, South Africa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

A review of tuberculosis: reflections on the past, present and future of a global epidemic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

Preventing tuberculosis with bacillus Calmette-Guérin vaccine: a meta-analysis of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

Treatment of multidrug-resistant tuberculosis during pregnancy: a report of 7 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

Pharmacodynamics of fluoroquinolones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

Pediatric use of quinolones

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

Early bactericidal activity of moxifloxacin in treatment of pulmonary tuberculosis: a prospective, randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

Rapid detection of rifampin resistance in Mycobacterium tuberculosis isolates by heteroduplex analysis and determination of rifamycin cross-resistance in rifampin-resistant isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

Use of rifabutin in the treatment of pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

Rifampin and rifabutin drug interactions: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

Ethionamide activation and sensitivity in multidrug-resistant Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

Hypothyroidism due to ethionamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

Mutant prevention concentration: comparison of fluoroquinolones and linezolid with Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

Adjuvant interferon gamma in patients with drug - resistant pulmonary tuberculosis: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

Regional deposition of aerosolized interferon-gamma in pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

Treatment of multidrug-resistant pulmonary tuberculosis with interferon-gamma via aerosol

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

Resistance to antituberculosis medications: hard lessons to learn.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

Preclinical testing of the nitroimidazopyran PA-824 for activity against Mycobacterium tuberculosis in a series of in vitro and in vivo models

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

Prospects for clinical introduction of nitroimidazole antibiotics for the treatment of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

Effectiveness of once-weekly rifapentine and moxifloxacin regimens against Mycobacterium tuberculosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

Evaluation of the fully automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide, streptomycin, isoniazid, rifampin, and ethambutol and comparison with the radiometric BACTEC 460TB method

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

Photographic and luminometric detection of luciferase reporter phages for drug susceptibility testing of clinical Mycobacterium tuberculosis isolates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

Detection of a point mutation associated with high-level isoniazid resistance in Mycobacterium tuberculosis by using real-time PCR technology with 3'-minor groove binder-DNA probes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

Direct detection of rifampin- and isoniazid-resistant Mycobacterium tuberculosis in auramine-rhodamine-positive sputum specimens by real-time PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

Evaluation of a PCR-based universal heteroduplex generator assay as a tool for rapid detection of multidrug-resistant Mycobacterium tuberculosis in Peru

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

Rapid detection of ofloxacin resistance in Mycobacterium tuberculosis by two low-cost colorimetric methods: resazurin and nitrate reductase assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

Recent developments in tuberculosis vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

Real world TB vaccines: clinical trials in TB-endemic regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

Current progress in tuberculosis vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

Worldwide Incidence of Multidrug‐Resistant Tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

Origin and Interstate Spread of a New York City Multidrug-Resistant Mycobacterium tuberculosis Clone Family

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.995

21 January 2018

Identifiers

DOI

10.1586/14787210.3.6.995

1 reference

13 August 2017

1 reference

PubMed ID

16307511